MISCHZELLEN-GENTHERAPIE

European patent · EP1490074 · Deleted

Register entry

Publication number
EP1490074
Application number
EP03718103
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 28, 2003
Published
Dec 29, 2004
Granted
May 10, 2017
Deleted
Mar 28, 2023
Reason
Maximum term reached
IPC classes
A61K 48/00 (2006.01)
A61K 35/12 (2015.01)
A61K 35/32 (2015.01)
A61K 35/33 (2015.01)
C12N 5/077 (2010.01)
Priority
US 369162 P 29.03.2002
PCT application
PCT/US2003/009720 28.03.2003
PCT publication
WO2003/083080 09.10.2003
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 28, 2023

    Maximum term reached

    Published in Swissreg on 28.03.2023

  2. Sep 23, 2020

    Address changed

    Representative
    Keller Schneider Patent- und Markenanwälte AG, Beethovenstrasse 49, 8002 Zürich → Keller Schneider Patent- und Markenanwälte AG (Bern), Eigerstrasse 2, Postfach, 3000 Bern 14

    Published in Swissreg on 23.09.2020

  3. Sep 22, 2020

    Address changed

    Representative
    Keller & Partner Patentanwälte AG, Eigerstrasse 2, Postfach, 3000 Bern 14 → Keller Schneider Patent- und Markenanwälte AG, Beethovenstrasse 49, 8002 Zürich

    Published in Swissreg on 22.09.2020

  4. May 7, 2019

    Address changed

    Owner
    TissueGene, Inc., 9605 Medical Center Drive, Suite 200, Rockville, MD 20850, USA → Kolon TissueGene, Inc., 9605 Medical Center Drive, Suite 200, Rockville, MD 20850, USA

    Published in Swissreg on 07.05.2019

  5. Aug 11, 2017

    Address changed

    Owner
    TissueGene, Inc., 209 Perry Parkway, Suite 13, Gaithersburg, MD 20877, USA → TissueGene, Inc., 9605 Medical Center Drive, Suite 200, Rockville, MD 20850, USA

    Published in Swissreg on 11.08.2017

  6. Aug 11, 2017

    Agent entered

    Representative
    Keller & Partner Patentanwälte AG, Eigerstrasse 2, Postfach, 3000 Bern 14

    Published in Swissreg on 11.08.2017

  7. May 10, 2017

    Granted

    Published in Swissreg on 10.05.2017

Parties

Holder

Kolon Tissuegene, Inc.

Kolon TissueGene, Inc.

9605 Medical Center Drive, Suite 200, Rockville, MD 20850, US

Agent

Keller Schneider Patent- und Markenanwälte AG

Keller Schneider Patent- und Markenanwälte AG (Bern)

Eigerstrasse 2 Postfach, 3000 Bern 14

Inventor

SONG, Sun Uk, Clinical Reseach Center

Inchon, 400-711, KR

YI, Youngsuk

Gaithersburg, MD 20877, US

LEE, Kwan Hee

Gaithersburg, MD 20877, US

NOH, Moon Jong

Gaithersburg, MD 20877, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.